Skip to main content

Table 1 Patient characteristics at baseline

From: Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial

Characteristics Overall (n = 112) Brief Advice (n = 60) MET-CBT (n = 52)
Age (in years) 25.1 ± 6.1 25.4 ± 5.8 24.8 ± 6.4
Race
 White 36 (32.4%) 19 (32.2%) 17 (32.7%)
 Black 59 (53.2%) 31 (52.5%) 28 (53.8%)
 Other 16 (14.4%) 9 (15.3%) 7 (13.5%)
Hispanic ethnicity
 Yes 29 (25.9%) 17 (28.3%) 12 (23.1%)
 No 83 (74.1%) 43 (71.7%) 40 (76.9%)
Education (in years)
  < 12 39 (35.1%) 20 (33.3%) 19 (37.3%)
 12 42 (37.8%) 20 (33.3%) 22 (43.1%)
 13–15 25 (22.5%) 16 (26.7%) 9 (17.7%)
  ≥ 16 5 (4.5%) 4 (6.7%) 1 (2.0%)
Type of insurance/payer
 Medicaid 106 (94.6%) 54 (90.0%) 52 (100.0%)
 Other 6 (5.4%) 6 (10.0%) 0 (0.0%)
Parity
 0 42 (37.5%) 22 (36.7%) 20 (38.5%)
 1 34 (30.4%) 21 (35.0%) 13 (25.0%)
  ≥ 2 36 (32.1%) 17 (28.3%) 19 (36.5%)
Gestation age at time of enrollment, weeks 20.1 ± 7.2 20.3 ± 7.3 20.0 ± 7.2
Primary drug
 Alcohol 36 (32.1%) 18 (30.0%) 18 (34.6%)
 Cocaine 23 (20.5%) 12 (20.0%) 11 (21.2%)
 Marijuana 44 (39.3%) 24 (40.0%) 20 (38.5%)
 Other 9 (8.0%) 6 (10.0%) 3 (5.8%)
Ever regularly used more than one substance
 Yes 57 (51.8%) 33 (56.9%) 24 (46.2%)
 No 53 (48.2%) 25 (43.1%) 28 (53.8%)
MINI drug/alcohol abuse/dependence
 Yes 36 (32.1%) 23 (38.3%) 13 (25.0%)
 No 76 (67.9%) 37 (61.7%) 39 (75.0%)
  1. MET-CBT motivational enhancement therapy with cognitive behavioral therapy, MINI Mini-International Neuropsychiatric Interview. Statistics were reported as n (%) or mean ± standard deviation. Percentages may not add up to 100% due to rounding